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Monitoring global health
Problems are primarily national
Editor—Murray et al urge for improved
global reporting of health data.1 They also
highlight the difficulty of showing national
decision makers that good health data can
strongly support decision making.Why is this?
A reason may be that data are always
subject to interpretation. The article by Mur-
ray et al is a case in point. They want to
establish “an independent monitoring
organisation,” arguing that the World Health
Organization is not fit to undertake the job
because of tension between advocacy, moni-
toring, and evaluation. But evidence that it is
this tension that leads to poor monitoring by
WHO is weak, at best.
In reality, the problems of global health
reporting are primarily national (and sub-
national). The fact that the sum of deaths
claimed by different programmes is greater
than the actual number of deaths reflects
epidemiological methods and the current
limitations in global health reporting, more
than any WHO failure. The global burden of
disease project was limited by these issues,
but it was undertaken as effectively in WHO
as in any other organisation.
Not only are there problems in capacity,
understanding the value of surveillance, and
coverage of health services. The reporting of
health events can be politically sensitive or
even economically damaging. It is therefore
likely that political interference will continue
(whoever collects the data) until govern-
ments can be shown that honesty pays. It is
perhaps this failure that needs to be dealt
with rather than setting up yet another
organisation without a proper analysis of
the reasons (and locus) for failures in global
health reporting.
Osman David Mansoor public health physician
Public Health Consulting, 4/14 College Street,
Wellington, New Zealand
oz@phc.org.nz
Nick Wilson senior lecturer
Department of Public Health, Wellington School of
Medicine and Health Sciences, PO Box 7343,
Wellington South 6005, New Zealand
Competing interests: Both authors have worked
for WHO.
1 Murray CJL, Lopez AD, Wibulpolprasert S. Monitoring
global health: time for new solutions. BMJ 2004;329:1096-
100. (6 November.)
WHO has mandate and expertise
Editor—In their critique of procedures
of the World Health Organization for
analysing and presenting health statistics,
Murray et al make a series of misleading
statements about monitoring and evalua-
tion of tuberculosis.1 Ironically, part of
the reason that they can criticise WHO’s
tuberculosis statistics is that, by design,
WHO is completely open about the process
of gathering, analysing, and presenting
data.
We refer to just three issues among
many more.
Firstly, it is untrue that no affordable
and feasible methods are currently available
to assess tuberculosis in a community.
China, India, and other countries have
carried out a series of large scale population
surveys of infection and disease that
have shown, or have the potential to show,
the impact of their tuberculosis control
programmes.2 3
Secondly, after years of exposure to
these statistics, Murray et al still do not seem
to understand the meaning of basic indica-
tors, such as case detection, and how they
are used in planning and evaluation. These
indicators are fully explained in our annual
report.4
Thirdly, we reject absolutely the sugges-
tion that WHO manipulates global tubercu-
losis statistics so as to advocate for the
directly observed therapy, short course
(DOTS) strategy, and fails to expose
weaknesses in the data. With reference to
Mozambique, the example chosen by
Murray et al, our 2004 report clearly
pointed out the strengths and weaknesses
of the data.
WHO now routinely collects tuberculo-
sis statistics from 200 countries, and the
quality and diversity of the data on
surveillance, planning, and financing are
improving each year. We do not need
another global health monitoring organisa-
tion that would dilute this effort and would
do little to enable countries to use their data
to correct their own problems. We need
instead further international support for
WHO and its established partners, which
collectively have the mandate and expertise
to carry out this work.
Christopher Dye coordinator, Tuberculosis
Monitoring and Evaluation
dyec@who.int
Mario Raviglione director
Stop Tuberculosis Department, World Health
Organization, CH-1211 Geneva 27, Switzerland
Competing interests: Both authors work for
WHO.
1 Murray CJL, Lopez AD, Wibulpolprasert S. Monitoring
global health: time for new solutions. BMJ 2004;329:1096-
100. (6 November.)
2 China Tuberculosis Control Collaboration. The effect of
tuberculosis control in China. Lancet 2004;364:417-22.
3 Chadha VK, Kumar P, Gupta J, Jagannatha PS,
Lakshminarayana, Magesh V, et al. The annual risk of
tuberculous infection in the eastern zone of India. Int J
Tuberculosis Lung Dis 2004;8:537-44.
4 World Health Organization. Global tuberculosis control:
surveillance, planning, financing. Geneva: WHO, 2004.
Bottom up approach is more likely to be
successful
Editor—Murray et al identify the need for
better health information, but their solution
is misguided.1 How would their proposal for
a richly funded “independent” organisation,
primarily concerned with global monitoring
be useful to countries?
Such top down, technocratic approaches
emphasise global comparability at the
expense of countries’ ownership. Murray et
al assume a priori that addressing the
problems with global reporting will also
fuel greater commitment among countries
to strengthening national health informa-
tion systems. This approach was used in the
work of the World Health Organization that
was led by Murray, on burden of disease,
health system performance, and the world
health survey. The results were an over-
emphasis on model building and global
comparability, with tenuous links to empiri-
cal evidence and a notable absence of
involvement from countries. WHO is now
working to support the building of country
information systems from the ground up
while not neglecting its global monitoring
role.
Bottom up approaches will not only
generate data for country decision making
but also produce the information needed by
donors and international organisations for
global monitoring. This is the underlying
premise of the Health Metrics Network, a
new global alliance aiming to increase the
availability and use of sound data through
the reform of country health information
systems.
Examples abound of productive inter-
action between global monitoring and
country information systems. Estimates of the
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AIDS epidemic are generated by countries
themselves using standardised methods.2 3
In addition to empowering countries and
stimulating the use of data for health action,
this approach shows the importance of
solid surveillance systems to countries.
Capacity building in countries is therefore
producing not only better country data
but also better global monitoring. It
would be wise to build on the current
momentum of partnership and collabora-
tion led by the Health Metrics Network and
WHO.
Ties Boerma director,Measurement and Health
Information Systems
boermat@who.int
Carla Abou-Zahr interim executive secretary, Health
Metrics Network
World Health Organization, 1245 Geneva,
Switzerland
Competing interests: TB and CAZ work for
WHO in Geneva and are involved in the Health
Metrics Network.
1 Murray CJL, Lopez AD, Wibulpolprasert S. Monitoring
global health: time for new solutions. BMJ 2004;329:1096-
100. (6 November.)
2 Walker N, Stanecki KA, Brown T, et al. Methods and proce-
dures for estimating HIV/AIDS and its impact: the
UNAIDS/WHO estimates for the end of 2001. AIDS
2003;17:2215-25.
3 Garnett GP, Grassly NC, Boerma JT, Ghys PD. Maximising
the global use of HIV surveillance data through the devel-
opment and sharing of analytical tools. Sex Transm Infect
2004;80:i1-i4.
Cochrane Collaboration in developing
world could be an answer
Editor—The need to develop and maintain
a robust health information system that is
free from political influence is undoubtedly
important. The health promotion field of
the Cochrane Collaboration has also recog-
nised this need, identified priority areas of
global importance, and is commissioning
reviews.1 The suggestion by Murray et al of
an independent global organisation sounds
similar to the ideals of the Cochrane
Collaboration but seems to have a wider
scope.2
One of the problems with such organi-
sations is that these centres are usually
based in a developed country—for example,
most centres of the Cochrane Collabora-
tion are located in the developed world.
An alternative to creating a new body
looking at health information could be
to help support establishing regional or
national centres of a collaboration in the
developing world; rather than to have
yet another organisation based in a
developed country. In my view, this is
more likely to contribute to the develop-
ment of a robust global health information
system.
Ilyas Mirza consultant psychiatrist
Naseberry Court, Chingford, London E4 9QJ
ilyasmirza@blueyonder.co.uk
Competing interests: IM has an active interest in
setting up an independent centre for research
evaluation and dissemination in South Asia.
1 Waters E, Doyle J. Systematic reviews of public health in
developing countries are in train. BMJ 2004;328:585.
2 Murray CJL, Lopez AD, Wibulpolprasert S. Monitoring
global health: time for new solutions. BMJ 2004;329:1096-
100. (6 November.)
Limitations and potential of
country of birth as proxy for
ethnic group
Editor—We agree with Jarman and Aylin
that recording of ethnic group on death cer-
tificates needs to be improved in the United
Kingdom.1
Currently, country of birth has been
included in each UK census since 1841 and
is a readily available and objective, although
crude, method of ethnic group classifica-
tion.2 Indeed it remains a good proxy for
ethnic group for the older age minority
groups and is of intrinsic interest in
separating environmental and genetic dif-
ferences. However, it is no longer an appro-
priate proxy as it does not take account of
the diversity of the country of origin of the
individual; the number of white people
born in countries, such as India, ruled by
the British Empire; and children of
migrants identified by this method as
second generation immigrants. In the 2001
census half of the minority ethnic
population was born outside the United
Kingdom.
Further recording of country of birth on
death certificates, which is reliant on an
informant, may be less accurate than on the
census, when the person is still alive to pro-
vide the information, leading to the possibil-
ity of numerator-denominator bias. Previous
analyses of mortality by country of birth
have grouped together countries for which
this is a particular issue—South Asian
countries3—but this approach obscures
potentially important differences between
countries of birth.2 3 4
Despite these limitations, we have docu-
mented the marked variations in mortality
by age, sex, and ethnic group.5 This resource
is available online and provides a wide range
of data both on the morbidity and mortality
by ethnic group that is of use for
commissioning services for these minority
communities. However, there is an urgent
need to address the recording of ethnic
group data on death certificates to
accurately determine and address the health
inequalities between ethnic groups in the
United Kingdom.
Paramjit S Gill clinical senior lecturer
University of Birmingham, Birmingham B15 2TT
p.s.gill@bham.ac.uk
Raj Bhopal professor of public health
Sarah Wild senior lecturer
Public Health Sciences Section, Division of
Community Health Sciences, University of
Edinburgh, Edinburgh EH8 9AG
Joe Kai professor of primary care
University of Nottingham, Graduate Medical
School, Derby City General Hospital, Derby
DE22 3DT
Competing interests: None declared.
1 Jarman B, Aylin P. Death rates in England and Wales and
the United States: variation with age, sex, and race. BMJ
2004;329:1367. (11 December.)
2 Aspinall PJ, Jacobson B, Polato GM. Missing record: the
case for recording ethnicity at birth and death registration.
www.lho.org.uk/Publications/Attachments/Word_Files/
Civil_Registration_Report.doc (accessed 15 Dec 2004).
3 Marmot MG, Adelstein AM, Bulusu L, Shukla V. Immigrant
mortality in England and Wales 1970-78. London: HMSO,
1984. (OPCS studies on population and medical subjects:
No 47.)
4 Wild S,Mckeigue P. Cross sectional analysis of mortality by
country of birth in England and Wales, 1970-92.
BMJ1997;314:705.
5 Gill PS, Kai J, Bhopal RS, Wild S. Health care needs assess-
ment: black and minority ethnic groups. In: Raftery J, Ste-
vens A, Mant J, eds. Health care needs assessment. The
epidemiologically based needs assessment reviews. 3rd series.
Abingdon: Radcliffe Medical Press (in press). Available
at: http://hcna.radcliffe-oxford.com/bemgframe.htm
(accessed 15 Dec 2004).
Specialised care for early
psychosis
Like was not compared with like
Editor—Craig et al tried to evaluate early
intervention services for psychosis empiri-
cally.1 The results of the Lambeth Early
Onset (LEO) trial may, however, be mis-
represented, especially by those who think
that early intervention services are a waste of
valuable resources,2 and be used to argue
that resources should be directed to
inadequately resourced routine services, the
supposed comparison group in the LEO
trial.
The comparison in the LEO trial was
not between a well funded specialist team
and run down inner city services, but
between a newly formed specialist team that
was learning on the job and between well
established and integrated community men-
tal health teams. A randomised controlled
trial of a developing team at its inception is
the equivalent of conducting a clinical
trial on a drug without first establishing
its pharmacokinetic and pharmacodynamic
properties.
ETHOS, the neighbouring early inter-
vention service in southwest London, was set
up in July 2001. The ETHOS team has taken
three years to determine the key ingredients
of effective biological and psychosocial
interventions for its patients, the appropri-
ate generic and specialist skill mix of the
team, the duration of service provision,
pathways into and out of care, and strategies
for preventing relapse.
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Despite all the problems entailed in
developing and establishing a new service,
the LEO trial shows some positive outcomes
for patients receiving early intervention. It
would be unfortunate therefore if the
limited effectiveness of LEO intervention
simply strengthens the prejudices of the
nay-sayers and confirms the principle of
dangerous precedent: nothing should ever
be done for the first time.
Swaran P Singh senior lecturer in mental health
St George’s Hospital Medical School, London
SW17 0RE
s.singh@sghms.ac.uk
Competing interests: SPS has established and
run the ETHOS early intervention in psychosis
service.
1 Craig TKJ, Garety P, Power P, Rahaman N, Colbert S,
Fornells-Ambrojo M, et al. The Lambeth early onset (LEO)
team: randomised controlled trial of the effectiveness of
specialised care for early psychosis. BMJ 2004;329:1067-9.
(6 November.)
2 Pelosi AJ, Birchwood M. Is early intervention for psychosis
a waste of valuable resources? Br J Psychiatry
2003;182:196-8.
More detail is needed
Editor—Craig et al evalu-
ated the effectiveness of spe-
cialised care for early psy-
chosis.1 This is a good first
step. What is different in the
early intervention team work
needs to be described more
fully—for example, the fre-
quency and regularity of
appointments in assertive
outreach and standard care.
People with schizophre-
nia benefit from a regimen
that gives them something in
the near future on which to anchor their
inner thoughts, something to look forward
to and reassemble “connecting” ability to
outside expectation, rather than drifting.
What is described is rather like a manifesto.
Some idea of the numbers of people who
were offered and took up cognitive behav-
iour therapy, vocational guidance, and
particularly occupational activities that
brought about “breaks” would be helpful.
David H Yates retired psychiatrist
Wadebridge, Cornwall PL27 7RE
david@jidgey.freeserve.co.uk
Competing interests: None declared.
1 Craig TKJ, Garety P, Power P, Rahaman N, Colbert S,
Fornells-Ambrojo M, et al. The Lambeth early onset (LEO)
team: randomised controlled trial of the effectiveness of
specialised care for early psychosis. BMJ 2004;329:1067-9.
(6 November.)
Author’s reply
Editor—The Lambeth Early Onset (LEO)
community team comprised experienced
mental health professionals, most of whom
had not previously worked in an early inter-
vention service and were comparative
novices at the interventions advocated by
international experts. However, we contend
that our pragmatic approach is precisely
how many similar early intervention teams
are being established, so that our results
reflect the least that may be expected from
these new services.
Although it may also have been better to
have waited until the early intervention serv-
ice was fully established, randomisation to
non-specialist care would have been impos-
sible to justify once the service had been
running for two or three years—an observa-
tion that probably accounts for the dearth of
relevant randomised controlled trials.
We will provide more detail on the proc-
ess and outcomes of the LEO team later, but
a few clarifications may be helpful. The work
of the LEO community team differed from
comparison sector teams mostly in terms of
intensity. Patients in LEO were seen more
frequently (an average of 13 visits in the first
three months out of hospital compared with
five for standard care).
Much of the effort was to help patients
resume aspects of their life that had been
disrupted by illness. Occupational and social
activities were accorded as much impor-
tance as management of symptoms. Presum-
ably as a result, LEO patients were more
likely to continue drug treatment, with 50%
still adherent at nine months compared with
fewer than 30% in standard
care. They spent twice as
much of the follow up
engaged in education or
employment and had more
satisfactory relationships
with friends and family. Just
over half of them took up
offers of cognitive behaviour
therapy for positive symp-
toms, and some family work
was carried out in 40 LEO
families, although this
entailed mainly advice and
support rather than formal therapy.
Tom K J Craig professor of social and community
psychiatry
Institute of Psychiatry, London SE5 8AF
tcraig@iop.kcl.ac.uk
Competing interests: TKJC has received support
for attending seminars and fees for speaking at
conferences on early psychosis from Eli Lilly,
AstraZeneca, Janssen-Cilag, and Novartis.
Computer assisted knee
arthroplasty is here today
Editor—Gidwani et al summarise the
orthopaedic options for painful arthritis of
the knee.1 As they say, computer assisted
surgery is not standard practice for most
orthopaedic surgeons in the United King-
dom.Many cite a lack of long term follow up
data for this technique to justify their
reluctance to embrace this technology.
However, navigated arthroplasty surgery
has been widely validated in the orthopaedic
literature.2 3 Lower limb mechanical align-
ment is one of the principal factors
determining the survival of a total knee
arthroplasty. As many as 10-15% of all knee
prostheses ultimately require revision, many
because of poor quality placement of the
prosthetic components.4 The failure rate of
poorly aligned implants is more than twice
that of well aligned implants.5
The main reason for poor alignment
arises from the difficulty of using anatomi-
cal reference points, and human judgment
alone cannot ensure reproducible align-
ment. Mechanical alignment outcomes
obtained using computer assisted surgery
have consistently been superior to those
obtained using traditional alignment meth-
ods.2 3 Most data on survival of total knee
arthroplasties originate from centres
specialising in such surgery and therefore
do not reflect the normal Gaussian spread
of outcome obtained throughout the
country.
Computer assisted arthroplasty narrows
the spread of alignment and so improves
the long term outcome of such surgery.
Interestingly, few orthopaedic surgeons
formally assess postoperative mechanical
alignment by lower limb alignment films
or computer tomography. Despite their
inability to assess their outcomes, many
would state that their technique does not
require modification. We think this shows a
lack of insight which must be addressed to
maximise the survival of arthroplasties.
Graeme Holt specialist registrar, trauma and
orthopaedic surgery
graemeholt@btinternet.com
A G Gregori consultant trauma and orthopaedic
surgeon
Hairmyres Hospital, East Kilbride, Glasgow
G75 8RG
Competing interests: None declared.
1 Gidwani S, Fairbank A. The orthopaedic approach to
managing osteoarthritis of the knee. BMJ
2004;329:1220-4. (20 November.)
2 Oberst M, Bersch C, Wurstlin S, Holz U. CT analysis of leg
alignment after conventional vs. navigated knee prosthesis
implantation. Initial results of a controlled, prospective
and randomised study. Unfallchirurg 2003;106:941-8.
3 Saragaglia D, Picard F, Chaussard C, Montbarbon E,
Leitner F, Cinquin P. Computer assisted knee arthroplasty:
comparison with a conventional procedure. Rev Chir
Orthop Reparatrice Appar Mot 2001;87:18-28.
4 Coyte PC, Hawker G, Croxford R, Wright JG. Revision
knee replacement in Ontario, Canada. J Bone Joint Surg Am
1999;81:773-82.
5 Ritter MA, Faris PM, Keating EM, Meding JB. Post-
operative alignment of total knee replacement. Its effect on
survival. Clin Orthop 1994; 299:153-6.
Preventing and treating
hepatitis B infection
Immunisation is most important strategy
to control hepatitis B
Editor—The immunisation advice in the
hepatitis B review by Aggarwal and Ranjan
is potentially misleading.1
Firstly, recommending three doses at 0,
1, and 6 months is unnecessarily limiting;
delaying the third dose can lead to lower
compliance. Hepatitis B vaccine has been
shown to be immunogenic when a wide
range of schedules is used.2 Although
increasing the time between the second and
third doses leads to higher antibody concen-
trations, it seems to be the immune memory
rather than antibody concentrations that is
of primary importance. A two dose schedule
was approved for adolescents in the United
States in 1999; it has also been suggested as
being adequate for infants.3
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Secondly, the importance of hepatitis B
immune globulin is overstated. It provides
comparatively little additional protection to
immunisation in preventing infection in
infants of HBeAg positive mothers.4 5
Thirdly, although recommending giving
vaccine to infants of HBeAg positive
mothers as soon as possible after birth is
reasonable, the data are limited on the
precise timing. A dose of hepatitis B vaccine
given with immunisation leads to higher
protection (70% to 95%) than if given after
one week (50% to 57%),2 w1–w3 but one
study found protective efficacy of 75% for
those who received vaccine alone in week
two.w4
As the authors note, immunisation is the
most important strategy in controlling
hepatitis B.
Osman David Mansoor public health physician
Public Health Consulting, 4/14 College Street,
Wellington, New Zealand
oz@phc.org.nz
Nick Wilson senior lecturer
Department of Public Health Wellington, School of
Medicine and Health Sciences, PO Box 7343,
Wellington South 6005, New Zealand
Competing interests: None declared.
1 Aggarwal R, Ranjan P. Preventing and treating hepatitis B
infection. BMJ 2004;329:1080-6. (6 November.)
2 West DJ, Calandra GB, Hesley TM, Ioli V, Miller WJ. Con-
trol of hepatitis B through routine immunization of
infants: the need for flexible schedules and new combina-
tion vaccine formulations. Vaccine 1993;11(suppl 1):S21-7.
3 Nokes DJ, Wilson JN. Do we need 3 doses of hepatitis B
vaccine? Vaccine 1999;17:2667-73.
4 Andre FE, Zuckerman AJ. Review: protective efficacy of
hepatitis B vaccines in neonates. J Med Virol 1994;44:
144-51.
5 Poovorawan Y, Sanpavat S, Pongpunglert W,Chumdermpa-
detsuk S, Sentrakul P, Vandepapelière P, et al. Long term
efficacy of hepatitis B vaccine in infants born to hepatitis B e
antigen-positive mothers.Pediatr Infect Dis J 1992;11:816-21.
High risk groups are still not being
vaccinated
Editor—Aggarwal and Ranjan highlighted
the global burden of hepatitis B and say that
vaccination is the mainstay of prevention.1
They also describe the vaccination’s lifelong
efficacy and cost effectiveness. With such a
clear evidence base and the recognition that
certain high risk groups—such as injecting
drug users—must be vaccinated, the avail-
ability of vaccination services to this popula-
tion is disappointing.
In a recent national survey of all UK
drug treatment agencies, only a quarter of
drug services routinely provided hepatitis
testing and vaccination for hepatitis B, and a
quarter did not offer this service at all.2
Often associated with equally limited access
to hepatitis C testing, the absence of such
service provision not only needlessly
exposes vulnerable individuals to prevent-
able risk but also denies the chance for posi-
tive behavioural change that can be seen in
those who are made aware of their viral
status.
The authors say that, in preference to
universal neonatal vaccination adopted in
countries with higher prevalence, a policy of
selective immunisation of high risk groups
has been implemented in the United
Kingdom. However, a large proportion of
injecting drug users in contact with treat-
ment agencies who should thus be ideally
placed to access and receive such interven-
tions clearly do not. The continued failure to
institute such health and cost effective
evidence based interventions to a marginal-
ised and high risk group is unacceptable and
inconsistent with UK policy and the
expectation of reasonable public health care
and harm reduction.
Adam R Winstock area clinical director
Drug Health Services, South Western Sydney Area
Health Service, PO Box 39, Liverpool BC,
NSW 1871, Australia
Adam.Winstock@swsahs.nsw.gov.au
Competing interests: None declared.
1 Aggarwal R, Ranjan P. Preventing and treating hepatitis B
infection. BMJ 2004;329:1080-6. (6 November.)
2 Winstock AR, Sheridan J, Lovell S, Farrell M, Strang J.
National survey of hepatitis testing and vaccination
services provided by drug services in England and Wales.
Eur J Clin Microbiol Infect Dis 2000;19:823-8.
Authors’ reply
Editor—We agree with Mansoor and
Wilson that hepatitis B vaccine has consider-
able efficacy even when the recommended
schedule is not strictly adhered to. Two doses
are possibly as effective as three doses, and
the time interval between the second and
the third doses may be unimportant.
Similarly, among infants born to HbeAg
positive mothers, delayed administration of
the vaccine or administration of vaccine
alone without hepatitis B immunoglobulin
seems to have considerable efficacy; how-
ever, whether this equals the efficacy of the
recommended measures remains unclear.
Our brief was to summarise the current
standard recommendations and these
remain unchanged despite the recent data.
As pointed out by Winstock, selective
immunisation strategies aimed at high risk
adolescents and adults do not work. We
therefore believe that it may be wise to
implement universal hepatitis B immunisa-
tion even in regions with low endemicity.
Rakesh Aggarwal additional professor
Piyush Ranjan senior research associate
Department of Gastroenterology, Sanjay Gandhi
Postgraduate Institute of Medical Sciences,
Lucknow 226014, India
rakesh@sgpgi.ac.in
Competing interests: None declared.
A prisoner of conscience in
Vietnam
Editor—In Vietnam, freedom of expression
is limited, and this restriction has an impact
on health services. Nguyen Dan Que has
spent nearly half his professional life in
prison for peaceful protest. He is an interna-
tionally trained doctor, capable of making a
valuable contribution to his country’s health
service.
Dr Que studied medicine at Saigon Uni-
versity and joined the teaching staff of the
university’s medical school. He specialised in
thyroid diseases and diabetes and in
1968-72 carried out research in Paris, Brus-
sels, and London under the sponsorship of
the World Health Organization. In 1974 he
returned to Vietnam to join the Saigon Uni-
versity Faculty of Medicine. In 1975 he
became director of Cho-Ray Hospital in Ho
Chi Minh City. He soon became disillu-
sioned with the new government’s health-
care policies and expressed criticisms
openly; he was dismissed as hospital
director.
In February 1978 Dr Que was arrested
and imprisoned without trial, under harsh
conditions, for 10 years. He was adopted as a
prisoner of conscience by Amnesty Interna-
tional and released in 1988. He was
prevented from practising medicine. He
refused to emigrate despite being invited to
do so by the authorities. He became the first
member of Amnesty International in Viet-
nam. In 1990, inspired by the democratic
movements in eastern Europe, Dr Que
founded the “high tide of humanism” move-
ment (Cao Trao Nhan Ban), a non-violent
movement for human rights. Its manifesto
called on people in Vietnam and abroad to
sign a petition demanding non-violent
political, social, and economic change for
Vietnam.
As a result he was arrested and in
November 1991 tried for, among other
things, planning to overthrow the govern-
ment and being a member of Amnesty
International. He was sentenced to 20 years’
imprisonment and five years’ house
arrest. He was long kept in solitary confine-
ment and developed hypertension and a
duodenal ulcer. Perhaps as a result of
international campaigning he was released
under a special amnesty in September 1998.
After his release, Dr Que faced constant
surveillance amounting to harassment,
including having his phone and access to
the internet cut on numerous occasions.
On 17 March 2003, he was arrested
again, reportedly while on his way to an
internet cafe. He was sentenced after a
grossly unfair trial, despite a wave of
international protest, to two and a half
years’ imprisonment.
His health has reportedly worsened in
prison. He requires drug treatment for
hypertension and has a bleeding peptic
ulcer and kidney stones. Drug treatment is
reportedly delivered to prison, but it is not
known whether he receives it or any other
medical care.
The Health Professionals’ Network of
Amnesty International is calling for support
for Dr Que. Only intensive international
campaigning can help him receive medical
treatment and his release.
Duncan Forrest editor, Amnesty International UK
Health Professionals’ Network Newsletter
Health Professionals’ Network, Amnesty
International, London EC1R 4RE
Duncan Forrest died on 4 December 2004. An
obituary will be published in the BMJ soon. The
contact for this letter is Natalie Smith, coordina-
tor, UK Health Professionals’ Network, Amnesty
International, London EC1R 4RE
(natalie.smith@amnesty.org.uk).
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